Rockwell Medical, Inc. ( RMTI) - Key Metrics
RMTI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.49 | -$0.30 | $0.53 | $0.37 |
| 2026Q1 | $4.40 | -$0.41 | -$0.04 | -$0.15 |
| 2025Q4 | $4.66 | -$0.14 | $0.58 | $0.56 |
| 2025Q3 | $4.42 | -$0.49 | -$0.36 | -$0.43 |
| 2025Q2 | $4.68 | -$0.43 | $0.54 | $0.49 |
RMTI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.05 |
| 2026Q1 | 0% | -5.45 |
| 2025Q4 | 0% | -14.89 |
| 2025Q3 | 0% | -6 |
| 2025Q2 | 0% | -4.93 |
RMTI Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 6.71% | 0% |
| 2026Q1 | -1.68% | 0% |
| 2025Q4 | 6.71% | 0% |
| 2025Q3 | -3.55% | 0% |
| 2025Q2 | 5.77% | 0% |
RMTI
Price: $7.08
52 week price:
Earnings Per Share: -1.32 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 309500
Ebitda: -4.9 millionMarket Capitalization: 34.1 million